CPC C12N 9/0083 (2013.01) [A61K 36/07 (2013.01); C12N 9/1007 (2013.01); C12N 9/1205 (2013.01); C12N 9/88 (2013.01); C12Y 114/99 (2013.01); C12Y 201/01 (2013.01); C12Y 207/01 (2013.01); C12Y 401/01 (2013.01)] | 19 Claims |
1. A genetically modified Basidiomycota fungus, comprising an expressed exogenous PsiD gene or an expressed exogenous PsiH gene, or both, and wherein the genetically modified Basidiomycota fungus produces an increased production of a compound selected from the group consisting of:
![]() and any combination thereof, as compared to production of the same compound(s) in a comparable control Basidiomycota fungus without the expressed exogenous PsiD gene or the expressed exogenous PsiH gene, or both, and wherein
the genetically modified Basidiomycota fungus comprises at least 200% more psilocybin measured by dry weight of the genetically modified Basidiomycota fungus compared to an amount of psilocybin in a comparable control Basidiomycota fungus without the expressed exogenous PsiD gene or the expressed exogenous PsiH gene, or both.
|